1.
An LC-MS/MS Method Development and Validation for the Quantification of Infigratinib in K2EDTA Human Plasma. Int. J. Pharm. Sci. Drug Res. [Internet]. 2024 Jan. 30 [cited 2025 Oct. 16];16(1):86-91. Available from: https://ijpsdronline.com/index.php/journal/article/view/8463